1. The Significance of Measuring Plasma Leptin in Acute Myocardial Infarction
- Author
-
K Fujita, Jun'ichi Tamura, Isao Kobayashi, S Fujimaki, and T Kanda
- Subjects
Leptin ,Male ,medicine.medical_specialty ,Myocardial Infarction ,030204 cardiovascular system & hematology ,Biochemistry ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,Lactate dehydrogenase ,Blood plasma ,medicine ,Humans ,In patient ,Myocardial infarction ,Interleukin 6 ,Aged ,L-Lactate Dehydrogenase ,biology ,business.industry ,Biochemistry (medical) ,Cell Biology ,General Medicine ,Middle Aged ,medicine.disease ,Pathophysiology ,Endocrinology ,chemistry ,030220 oncology & carcinogenesis ,biology.protein ,Female ,business ,Serum markers - Abstract
We measured leptin concentrations in patients with acute myocardial infarction (AMI, n = 21) and in 15 age-matched controls, and compared leptin concentrations with levels of other myocardial enzymes and indicators of AMI. Blood was sampled immediately after hospital admission and at 1 h, 2 h, 3 h, 6 h and 9 h, then every 12 h until 5 days post-admission. Patients were stratified into three groups according to peak leptin concentrations: hypoleptinaemia (< 3 ng/ml); normoleptinaemia (≥ 3 – < 15 ng/ml) and hyperleptinaemia (≥ 15 ng/ml). Hypoleptinaemic AMI patients had significantly increased concentrations of plasma lactate dehydrogenase compared with normoleptinaemic patients. No significant differences in other serum markers were noted between hyperleptinaemic and normoleptinaemic AMI patients. A significant negative correlation was found between the peak concentrations of leptin and interleukin 6. Leptin may play a role in the regulation of the development of cardiac damage in patients with AMI.
- Published
- 2001